Predicting prostate cancer biochemical recurrence using combined nuclear NF-KB/P65 localization and gland morphology
US10769783B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Dec 12, 2018 |
| Grant date | Sep 8, 2020 |
| Priority date | — |
| Expiry date | Feb 12, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG06T2207/30081
- WIPO fieldComputer technology
- WIPO sectorElectrical engineering
Abstract
Embodiments include controlling a processor to perform operations for predicting biochemical recurrence (BCR) in prostate cancer (PCa), including accessing a first digitized pathology slide having a first stain channel of a region of tissue demonstrating PCa; accessing a second digitized pathology slide having a second, different stain channel of the region of tissue; extracting morphology features from the first stain channel; extracting stain intensity features from the second stain channel, where a stain intensity feature quantifies an amount of a molecular biomarker present in a cellular nucleus; controlling a first machine learning classifier to generate a first probability of BCR based on the morphology features; controlling a second machine learning classifier to generate a second, different probability of BCR based on the stain intensity features; computing an aggregate probability of BCR based on the first probability and the second probability; and displaying the aggregate probability.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.